MD selected as Mentor for Endourological Society's Technology Innovation Program 2027
Tejnaksh Healthcare's Managing Director Dr. Ashish V. Rawandale-Patil has been selected as a Mentor for the Technology Innovation Program 2027 (ES-TIP 2027) of the Endourological Society.
By ScoutQuest · · 1 min read
- Mentor Program
- Technology Innovation Program 2027 (ES-TIP 2027)
- Mentor Panel
- only urologist from outside the United States among the mentors
- Other Mentors
- three others from leading US institutions
What the announcement says
- Dr. Ashish V. Rawandale-Patil, Managing Director of Tejnaksh Healthcare Limited, has been selected as a Mentor for the Technology Innovation Program 2027 (ES-TIP 2027) of the Endourological Society.
- The Endourological Society is described in the update as a globally recognised international organisation in the field of urology.
- The update states he is the only urologist from outside the United States to join the mentor panel, alongside three other distinguished mentors from leading institutions in the United States.
What the program does
- ES-TIP 2027 aims to support and mentor medical innovations.
- It assists healthcare professionals in developing novel ideas for improving patient care.
- Promising innovations are considered for further development and commercialisation.
How the company frames it
The update says the company believes this international recognition enhances the reputation and visibility of Tejnaksh Healthcare Limited and showcases the global expertise and leadership associated with the company. It also describes the recognition as reflecting the Managing Director's contribution to medical innovation and India's growing presence on the global healthcare innovation platform.
What this is and is not
- This is a personal professional recognition for the Managing Director, reported to the exchanges by the company.
- The update does not link the mentorship to any order, contract, revenue or commercial arrangement for the company.
- Investors reading this should treat it as a reputational and leadership-related update rather than a financial one.
Also from Tejnaksh Healthcare
Peer-reviewed validation study of Pflow™ published in Indian Journal of Urology
24 Oct 2026
Suhas Vasvantrao Thorat re-appointed Independent Director for a second term of 5 consecutive years
1 Oct 2026
More numbers
- Other distinguished mentors from leading US institutionsthree
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.